3

OWNERSHIP DOCUMENT

Company: BioXcel Therapeutics, Inc.
Filed: January 19, 2022
Period of Report: January 17, 2022
Accession Number: 0001104659-22-005446

View Document ↗ View on SEC.gov ↗